期刊文献+

中央型小细胞肺癌与肺鳞癌CT征象分析 被引量:7

Analysis of CT signs of central small cell lung cancer and lung squamous carcinoma
下载PDF
导出
摘要 目的分析中央型小细胞肺癌(small cell lung cancer,SCLC)及肺鳞癌(squamous carcinoma,SC)的CT表现,探讨各自影像学特点及鉴别诊断价值。方法选取2019年1月~2019年12月在我院经病理证实的SCLC及SC患者的临床及影像学资料,分为SCLC组30例,SC组31例,对两组肺癌患者的CT征象进行统计学分析。结果纵隔及肺门淋巴结肿大、淋巴结融合、支气管狭窄无阻塞、血管受侵、“沼泽样”强化在SCLC中出现概率高于SC组(P值均<0.05);支气管闭塞、阻塞征象及“湖泊样”强化在SC中出现概率高于SCLC组(P值均<0.05);其他征象均差异无统计学意义(P值均>0.05)。结论中央型SCLC与肺SC的CT征象差异在两者的诊断及鉴别诊断中具有一定价值。 Objective To analyze the CT imaging findings of central small cell lung cancer and lung squamous carcinoma,and to explore their imaging characteristics and differential diagnostic value.Methods The clinical and imaging data of patients with central small cell lung cancer and squamous carcinoma confirmed by pathology in our hospital from January 2019 to December 2019 were collected.They were divided into SCLC group of 30 cases,SC group of 31 cases.Statistical analysis of CT signs of lung cancer patients was conducted.Results Mediastinal hilar lymphadenopathy,lymph node fusion,bronchial stenosis without obstruction,vascular invasion,"marsh-like"enhancement were more likely to occur in SCLC(all P<0.05);The probability of occurrence of bronchial occlusion,obstruction signs,and"amber-like"enhancement was higher in SC than SCLC(all P<0.05).There were no statistical differences in other signs(all P>0.05).Conclusion The difference in CT signs between central SCLC and SC has certain value in the diagnosis and differential diagnosis of the two.
作者 李燕 董兰兰 LI Yan;DONG Lanlan(Department of Radiology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450000, P.R.China;Department of Radiology, Sanmenxia Central Hospital, Sanmenxia 472000, P.R.China)
出处 《医学影像学杂志》 2021年第4期586-589,共4页 Journal of Medical Imaging
关键词 小细胞肺癌 肺鳞癌 体层摄影术 X线计算机 Small cell lung cancer Lung squamous carcinoma Tomography,X-ray computed
  • 相关文献

参考文献13

二级参考文献81

  • 1宋磊,王峰,纪东华,张弦.恶性肿瘤所致上腔静脉压迫综合征的介入治疗[J].中国微创外科杂志,2008,8(4):355-359. 被引量:6
  • 2蒋晓东,戴鹏,吴瑾,宋大安,于金明.放疗联合周剂量重组人血管内皮抑素对A549肺腺癌裸鼠移植瘤生长抑制作用的研究[J].肿瘤,2010,30(11):917-923. 被引量:7
  • 3Lanciego C, Chacon JL, Julian A, et al. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol, 2001, 177:585-593.
  • 4Lanciego C, Pangua C, Chacon JI, et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. A JR Am J Roentgenol, 2009, 193:549-558.
  • 5周道安,王绿化,傅小龙,等.新编肺癌综合治疗学.第1版.上海:复旦大学出版社,2009:347-350.
  • 6Yim CD, Sane SS, Bjarnason H. Superior vena cava stenting. Radiol Clin North Am, 2000, 38:409-424.
  • 7Chamsangavej C, Carrasco CH, Wallace S, et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metal stents. Radiology, 1986, 161:295-298.
  • 8Kim YI, Kim KS, Ko YC, et al. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome. J Korean Med Sei, 2004, 19:519-522.
  • 9Garcta Monaco R, Bertoni H, Pallota G, et al. Use of self-expanding vascular endoprostheses in superior vena cava syndrome. Eur J Cardiothorac Surg, 2003, 24:208-211.
  • 10王荣品,唐斌,杨明放,邓奇平,秦华,苏友德.外围型小细胞肺癌的CT表现及分型[J].实用放射学杂志,2007,23(11):1468-1470. 被引量:7

共引文献149

同被引文献83

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部